KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Edwards Lifesciences (EW) over the last 15 years, with Q3 2025 value amounting to $587.2 million.

  • Edwards Lifesciences' Shares Outstanding (Diluted Average) fell 249.09% to $587.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $587.2 million, marking a year-over-year decrease of 249.09%. This contributed to the annual value of $599.3 million for FY2024, which is 165.74% down from last year.
  • As of Q3 2025, Edwards Lifesciences' Shares Outstanding (Diluted Average) stood at $587.2 million, which was down 249.09% from $587.9 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Shares Outstanding (Diluted Average) ranged from a high of $631.7 million in Q3 2021 and a low of $587.2 million during Q3 2025
  • Its 5-year average for Shares Outstanding (Diluted Average) is $613.0 million, with a median of $610.6 million in 2023.
  • Per our database at Business Quant, Edwards Lifesciences' Shares Outstanding (Diluted Average) skyrocketed by 46.2% in 2021 and then crashed by 293.93% in 2023.
  • Edwards Lifesciences' Shares Outstanding (Diluted Average) (Quarter) stood at $631.2 million in 2021, then fell by 1.11% to $624.2 million in 2022, then decreased by 2.37% to $609.4 million in 2023, then dropped by 1.66% to $599.3 million in 2024, then dropped by 2.02% to $587.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $587.2 million in Q3 2025, compared to $587.9 million in Q2 2025 and $587.8 million in Q1 2025.